Neurological Sciences

Papers
(The median citation count of Neurological Sciences is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Spectrum of neurological complications following COVID-19 vaccination153
Long-term neurological manifestations of COVID-19: prevalence and predictive factors78
Physical exercise effects on the brain during COVID-19 pandemic: links between mental and cardiovascular health70
Neuropathologic findings of patients with COVID-19: a systematic review64
Anxiety and depression in Alzheimer’s disease: a systematic review of pathogenetic mechanisms and relation to cognitive decline62
Direct and indirect neurological, cognitive, and behavioral effects of COVID-19 on the healthy elderly, mild-cognitive-impairment, and Alzheimer’s disease populations59
Hereditary spastic paraplegia54
Diagnosis and treatment of Chiari malformation and syringomyelia in adults: international consensus document53
Watch out for neuromyelitis optica spectrum disorder after inactivated virus vaccination for COVID-1952
Cognitive impairment in multiple sclerosis: diagnosis and monitoring51
COVID-19, de novo seizures, and epilepsy: a systematic review51
Effect of home-based virtual reality training and telerehabilitation on balance in individuals with Parkinson disease, multiple sclerosis, and stroke: a systematic review and meta-analysis51
Hereditary transthyretin amyloidosis overview49
Facing the digital divide into a dementia clinic during COVID-19 pandemic: caregiver age matters49
The effect of obstructive sleep apnea on the increased risk of cardiovascular disease: a systematic review and meta-analysis47
Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine46
Intracranial hemorrhage in coronavirus disease 2019 (COVID-19) patients45
Qualitative smell/taste disorders as sequelae of acute COVID-1944
A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine43
Epilepsy and quality of life: what does really matter?43
Early outcomes of migraine after erenumab discontinuation: data from a real-life setting42
Neurological manifestations of coronavirus disease 2019: exploring past to understand present41
Latent class cluster analysis identified hidden headache phenotypes in COVID-19: impact of pulmonary infiltration and IL-640
Structural and functional connections between the autonomic nervous system, hypothalamic–pituitary–adrenal axis, and the immune system: a context and time dependent stress response network39
Preliminary evidence of blunted humoral response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with ocrelizumab36
Subjective cognitive failures and their psychological correlates in a large Italian sample during quarantine/self-isolation for COVID-1935
Functional neurological disorder after COVID-19 vaccination35
Investigation of the peripheral inflammation (neutrophil–lymphocyte ratio) in two neurodegenerative diseases of the central nervous system35
Stroke and digital technology: a wake-up call from COVID-19 pandemic34
Clinical and neurophysiological characterization of muscular weakness in severe COVID-1933
Questionnaire-based survey on the prevalence of medication-overuse headache in Japanese one city—Itoigawa study33
Sex and gender differences in migraines: a narrative review33
Immune-mediated neurological syndrome in SARS-CoV-2 infection: a review of literature on autoimmune encephalitis in COVID-1933
Screening for cognitive sequelae of SARS-CoV-2 infection: a comparison between the Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA)33
Effectiveness of ketogenic diet in treatment of patients with refractory chronic migraine32
The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis32
New daily persistent headache after SARS-CoV-2 infection: a report of two cases31
Real-life assessment of erenumab in refractory chronic migraine with medication overuse headache30
New-onset refractory status epilepticus (NORSE) in post SARS-CoV-2 autoimmune encephalitis: a case report30
Diagnosis and treatment of Chiari malformation type 1 in children: the International Consensus Document29
Cognitive telerehabilitation in neurological patients: systematic review and meta-analysis29
Anxiety, depression, and worries in advanced Parkinson disease during COVID-19 pandemic29
How to manage with telemedicine people with neuromuscular diseases?29
Chemotherapy and peripheral neuropathy28
Myasthenia gravis exacerbation and myasthenic crisis associated with COVID-19: case series and literature review28
The vessel density of the superficial retinal capillary plexus as a new biomarker in cerebral small vessel disease: an optical coherence tomography angiography study28
Miller Fisher syndrome following Pfizer COVID-19 vaccine27
A systematic review of molecular approaches that link mitochondrial dysfunction and neuroinflammation in Parkinson’s disease27
Clinical presentation of strokes confined to the insula: a systematic review of literature27
Life with chronic pain during COVID-19 lockdown: the case of patients with small fibre neuropathy and chronic migraine26
Characteristics, onset, and evolution of neurological symptoms in patients with COVID-1926
Aseptic meningitis after vaccination of the BNT162b2 mRNA COVID-19 vaccine26
Cerebrolysin for stroke, neurodegeneration, and traumatic brain injury: review of the literature and outcomes26
Nanoparticles approaches in neurodegenerative diseases diagnosis and treatment25
Parkinson’s disease and virtual reality rehabilitation: cognitive reserve influences the walking and balance outcome25
Cognitive, behavioral, and psychological manifestations of COVID-19 in post-acute rehabilitation setting: preliminary data of an observational study25
The Frontal Assessment Battery 20 years later: normative data for a shortened version (FAB15)25
Cognitive dysfunction in amyotrophic lateral sclerosis: can we predict it?25
The impact of lockdown during SARS-CoV-2 outbreak on behavioral and psychological symptoms of dementia25
Functional autonomy in dementia of the Alzheimer’s type, mild cognitive impairment, and healthy aging: a meta-analysis24
Cardiovascular autonomic dysfunction after stroke24
The surgical treatment of epilepsy24
Psychometrics and diagnostics of Italian cognitive screening tests: a systematic review24
Assessment of gait and balance impairment in people with spinocerebellar ataxia using wearable sensors24
Guillain-Barré syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases24
Prevalence of multiple sclerosis (MS) in Iran: a systematic review and meta-analysis24
Facemask headache: a new nosographic entity among healthcare providers in COVID-19 era23
Norms and standardizations in neuropsychology via equivalent scores: software solutions and practical guides23
Neuralgic amyotrophy associated with COVID-19 infection: a case report and review of the literature23
Transcranial magnetic stimulation implementation on stroke prognosis23
NOTCH2NLC-related repeat expansion disorders: an expanding group of neurodegenerative disorders23
Gepants — a long way to cure: a narrative review23
Evaluation of an upper limb robotic rehabilitation program on motor functions, quality of life, cognition, and emotional status in patients with stroke: a randomized controlled study23
Mechanical thrombectomy in acute ischemic stroke due to large vessel occlusion in the anterior circulation and low baseline National Institute of Health Stroke Scale score: a multicenter retrospective22
An overview on amyotrophic lateral sclerosis and cadmium22
Neuro-telehealth for fragile patients in a tertiary referral neurological institute during the COVID-19 pandemic in Milan, Lombardy22
Clinical utility of home videos for diagnosing epileptic seizures: a systematic review and practical recommendations for optimal and safe recording22
Association of gender and age at onset with glucocerebrosidase associated Parkinson’s disease: a systematic review and meta-analysis22
Chronic fatigue syndrome and cognitive deficit are associated with acute-phase neuropsychiatric manifestations of COVID-19: A 9-month follow-up study22
Clinical features and cognitive sequelae in COVID-19: a retrospective study on N=152 patients21
Neurotoxicity and safety of the rechallenge of immune checkpoint inhibitors: a growing issue in neuro-oncology practice21
ADEM anti-MOG antibody-positive after SARS-CoV2 vaccination21
Are COVID-19 vaccines safe for people with epilepsy? A cross-sectional study21
Neurological toll of COVID-1921
Erenumab for the preventive treatment of chronic migraine complicated with medication overuse headache: an observational, retrospective, 12-month real-life study21
LncRNAs as putative biomarkers and therapeutic targets for Parkinson’s disease20
Neovascularization and tissue regeneration by endothelial progenitor cells in ischemic stroke20
Why is delirium more frequent in the elderly?20
A systematic review on the risk of neurodegenerative diseases and neurocognitive disorders in professional and varsity athletes20
Dysregulation of IGF-1/GLP-1 signaling in the progression of ALS: potential target activators and influences on neurological dysfunctions20
Can Systemic Immune-Inflammation Index (SII) be a prognostic factor of Bell’s palsy patients?20
The Frontal Assessment Battery (FAB) and its sub-scales: validation and updated normative data in an Italian population sample20
Randomized double-blind placebo-controlled trial of hydrogen inhalation for Parkinson’s disease: a pilot study20
Characterization and management of neurological adverse events during immune-checkpoint inhibitors treatment: an Italian multicentric experience20
Predictors of response to galcanezumab in patients with chronic migraine: a real-world prospective observational study19
Age- and gender-related differences in the evolution of psychological and cognitive status after the lockdown for the COVID-19 outbreak: a follow-up study19
Central nervous system adverse events after ChAdOx1 vaccination19
Impact of COVID-19 vaccine on epilepsy in adult subjects: an Italian multicentric experience19
The efficacy of ultrasound-guided stellate ganglion block in alleviating postoperative pain and ventricular arrhythmias and its application prospects19
Deep brain stimulation in Huntington’s disease: a literature review19
Parkinson’s disease and COVID-19: a systematic review and meta-analysis19
Factors affecting the behavior of children with ASD during the first outbreak of the COVID-19 pandemic18
Impact of COVID-19 pandemic on acute stroke care: facing an epidemiological paradox with a paradigm shift18
The links between diabetes mellitus and amyotrophic lateral sclerosis18
Effectiveness of a dance-physiotherapy combined intervention in Parkinson’s disease: a randomized controlled pilot trial18
Myasthenia gravis and telemedicine: a lesson from COVID-19 pandemic18
Clinical features and management of coexisting anti-N-methyl-D-aspartate receptor encephalitis and myelin oligodendrocyte glycoprotein antibody–associated encephalomyelitis: a case report and review o18
Hearing loss and dementia: radiologic and biomolecular basis of their shared characteristics. A systematic review.18
Neuroanatomical changes in early Parkinson’s disease with mild cognitive impairment: a VBM study; the Parkinson’s Disease Cognitive Impairment Study (PaCoS)18
The case of encephalitis in a COVID-19 pediatric patient18
Noise as a cause of neurodegenerative disorders: molecular and cellular mechanisms18
Sex influences clinical phenotype in frontotemporal dementia18
Chronic migraine in the first COVID-19 lockdown: the impact of sleep, remote working, and other life/psychological changes18
Frequency and clinical correlates of anti-nerve antibodies in a large population of CIDP patients included in the Italian database18
Do serum GDNF levels correlate with severity of Alzheimer’s disease?17
Alzheimer’s disease: the controversial approval of Aducanumab17
Neurofilament light chain as a disease severity biomarker in ATTRv: data from a single-centre experience17
COVID-19 in patients with Down syndrome17
Bell’s palsy following COVID-19 vaccination with high CSF antibody response17
Influence of the gut microbiome on inflammatory and immune response after stroke17
Air pollution and multiple sclerosis: a comprehensive review17
Tele-neuropsychological assessment tools in Italy: a systematic review on psychometric properties and usability17
Imaging and depression in multiple sclerosis: a historical perspective17
Shear wave elastography characteristics of upper limb muscle in rigidity-dominant Parkinson’s disease17
A night of sleep deprivation alters brain connectivity and affects specific executive functions17
The global prevalence of sexual dysfunction in women with multiple sclerosis: a systematic review and meta-analysis17
Cognitive deficit in post-acute COVID-19: an opportunity for EEG evaluation?16
Secular trends of ischaemic heart disease, stroke, and dementia in high-income countries from 1990 to 2017: the Global Burden of Disease Study 201716
Cyclophosphamide treatment in active multiple sclerosis16
Clinical, cerebrospinal fluid, and neuroimaging findings in COVID-19 encephalopathy: a case series16
Persistent chemosensory dysfunction in a young patient with mild COVID-19 with partial recovery 15 months after the onset16
Neurological manifestation of 22q11.2 deletion syndrome16
Intravenous thrombolysis before mechanical thrombectomy for acute ischemic stroke due to large vessel occlusion; should we cross that bridge? A systematic review and meta-analysis of 36,123 patients16
Research progress on oxidative stress regulating different types of neuronal death caused by epileptic seizures16
A review of ischemic stroke in COVID-19: currently known pathophysiological mechanisms16
Duchenne muscular dystrophy newborn screening: the first 50,000 newborns screened in Taiwan15
The effectiveness of cognitive-motor training on reconstructing cognitive health components in older male adults, recovered from the COVID-1915
Comparison of immersive and non-immersive virtual reality for upper extremity functional recovery in patients with stroke: a systematic review and network meta-analysis15
Narrative Medicine to integrate patients’, caregivers’ and clinicians’ migraine experiences: the DRONE multicentre project15
Gender differences in cognitive reserve: implication for subjective cognitive decline in women15
Heart rate variability and fatigue in MS: two parallel pathways representing disseminated inflammatory processes?15
The puzzle of fibromyalgia between central sensitization syndrome and small fiber neuropathy: a narrative review on neurophysiological and morphological evidence15
Sarcopenia in patients with dementia: correlation of temporalis muscle thickness with appendicular muscle mass15
Post-acute sequelae of SARS-CoV-2 infection (PASC): peripheral, autonomic, and central nervous system features in a child15
Safety and efficacy of melatonin, clonazepam, and trazodone in patients with Parkinson’s disease and sleep disorders: a randomized, double-blind trial15
The HALP (hemoglobin, albumin, lymphocyte, and platelet) score is associated with early-onset post-stroke cognitive impairment15
Evaluation of rTMS in patients with poststroke aphasia: a systematic review and focused meta-analysis15
Telemedicine application to headache: a critical review15
Patient’s point of view on the use of telemedicine in multiple sclerosis: a web-based survey15
The Italian tremor Network (TITAN): rationale, design and preliminary findings15
Retinal nerve fiber layer changes in migraine: a systematic review and meta-analysis15
Hemostasis components in cerebral amyloid angiopathy and Alzheimer’s disease15
Short- and long-term motor outcome of STN-DBS in Parkinson’s Disease: focus on sex differences15
Bilateral optic neuritis after COVID vaccination15
Whole blood viscosity is associated with baseline cerebral perfusion in acute ischemic stroke15
The prognostic value of the preoperative inflammatory index on the survival of glioblastoma patients15
Critical illness neuropathy in severe COVID-19: a case series15
Multidisciplinary care in Amyotrophic Lateral Sclerosis: a systematic review and meta-analysis15
ADEM post-Sars-CoV-2 infection in a pediatric patient with Fisher-Evans syndrome15
Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variables14
The effects of concurrent M1 anodal tDCS and physical therapy interventions on function of ankle muscles in patients with stroke: a randomized, double-blinded sham-controlled trial study14
Cerebrolysin after moderate to severe traumatic brain injury: prospective meta-analysis of the CAPTAIN trial series14
Favourable course in a cohort of Parkinson’s disease patients infected by SARS-CoV-2: a single-centre experience14
Chronic migraine evolution after 3 months from erenumab suspension: real-world-evidence-life data14
Robot-assisted distal training improves upper limb dexterity and function after stroke: a systematic review and meta-regression14
Functional MRI in Parkinson’s disease with freezing of gait: a systematic review of the literature14
Effectiveness of pharmacologic treatment for dysphagia in Parkinson’s disease: a narrative review14
Autoimmune encephalitis following ChAdOx1-S SARS-CoV-2 vaccination14
Focal seizures with impaired awareness as long-term neurological complication of COVID-19: a case report14
Cognitive and behavioral manifestations in SARS-CoV-2 infection: not specific or distinctive features?14
A novel PNPLA6 mutation in a Turkish family with intractable Holmes tremor and spastic ataxia14
Validation of a short Italian version of the Barratt Impulsiveness Scale (BIS-15) in non-clinical subjects: psychometric properties and normative data14
HSV encephalitis triggered anti-NMDAR encephalitis: a case report14
Prevalence, characteristics and risk factors in a Moroccan cohort of Long-Covid-1914
Temporal and extratemporal atrophic manifestation of temporal lobe epilepsy using voxel-based morphometry and corticometry: clinical application in lateralization of epileptogenic zone14
Ketogenic diet in refractory migraine: possible efficacy and role of ketone bodies—a pilot experience14
The management of Chiari malformation type 1 and syringomyelia in children: a review of the literature14
Effects of safinamide on non-motor, cognitive, and behavioral symptoms in fluctuating Parkinson’s disease patients: a prospective longitudinal study14
Regular physical activity postpones age of occurrence of first-ever stroke and improves long-term outcomes14
Brain magnetic resonance imaging and severity of neurological disease in Wilson’s disease — the neuroradiological correlations14
Internet addiction, headache, and insomnia in university students: a cross-sectional study13
Plasma neurofilament light chain levels are associated with depressive and anxiety symptoms in Parkinson’s disease13
Vestibular migraine: the chameleon in vestibular disease13
The association between stroke and COVID-19-related mortality: a systematic review and meta-analysis based on adjusted effect estimates13
Association of COMT rs4680 and MAO-B rs1799836 polymorphisms with levodopa-induced dyskinesia in Parkinson’s disease—a meta-analysis13
Network autonomic analysis of post-acute sequelae of COVID-19 and postural tachycardia syndrome13
Artificial intelligence analysis to explore synchronize exercise, cobalamin, and magnesium as new actors to therapeutic of migraine symptoms: a randomized, placebo-controlled trial13
The predictive value of platelet to lymphocyte ratio and D-dimer to fibrinogen ratio combined with WELLS score on lower extremity deep vein thrombosis in young patients with cerebral hemorrhage13
Rhino-orbito-cerebral mucormycosis during the COVID-19 third wave in 2021: an Egyptian preliminary report from a single tertiary hospital13
Guillain–Barré syndrome associated with BNT162b2 COVID vaccination: a first case report from South Korea13
The incidence and prevalence, diagnosis, and treatment of multiple sclerosis in China: a narrative review13
Subclinical myopathic changes in COVID-1913
Worldwide prevalence of neuromyelitis optica spectrum disorder (NMOSD) and neuromyelitis optica (NMO): a systematic review and meta-analysis13
Effects of quarantine applied during the COVID-19 pandemic on mental health and quality of life in patients with multiple sclerosis and healthy controls13
[18F]FDG brain PET and clinical symptoms in different autoantibodies of autoimmune encephalitis: a systematic review13
Postoperative neutrophil-to-lymphocyte ratio variation is associated with chronic subdural hematoma recurrence13
Safinamide improves sleep and daytime sleepiness in Parkinson’s disease: results from the SAFINONMOTOR study13
Effect of cognitive reserve on cognitive function in Parkinson’s disease13
Superoxide dismutase (SOD), advanced oxidation protein products (AOPP), and disease-modifying treatment are related to better relapse recovery after corticosteroid treatment in multiple sclerosis13
Efficacy and acceptability of the S1P receptor in the treatment of multiple sclerosis: a meta-analysis13
The effects and mechanisms of transcranial ultrasound stimulation combined with cognitive rehabilitation on post-stroke cognitive impairment13
The practice of teleneurology in the Philippines during the COVID-19 pandemic13
Low molecular weight heparin in COVID-19 patients prevents delirium and shortens hospitalization13
Telephone Interview for Cognitive Status (TICS): Italian adaptation, psychometrics and diagnostics13
Critical role of acute hypoxemia on the cognitive impairment after severe COVID-19 pneumonia: a multivariate causality model analysis13
Extra-motor manifestations in post-polio syndrome (PPS): fatigue, cognitive symptoms and radiological features13
Energy cost and psychological impact of robotic-assisted gait training in people with spinal cord injury: effect of two different types of devices13
Headache after COVID-19 vaccination: updated report from the Italian Medicines Agency database13
The modulatory effects of bilateral arm training (BAT) on the brain in stroke patients: a systematic review13
“Parkinson’s disease” on the way to progressive supranuclear palsy: a review on PSP-parkinsonism13
NEK1 mutations and the risk of amyotrophic lateral sclerosis (ALS): a meta-analysis13
Late epileptic seizures following cerebral venous thrombosis: a systematic review and meta-analysis13
Systematic review of risk of SARS-CoV-2 infection and severity of COVID-19 with therapies approved to treat multiple sclerosis13
The clinical correlation of proinflammatory and anti-inflammatory biomarkers with Alzheimer disease: a meta-analysis13
Orthostatic hypotension in patients with Alzheimer’s disease: a meta-analysis of prospective studies13
The role of the Sapienza GLObal Bedside Evaluation of Swallowing after Stroke (GLOBE-3S) in the prevention of stroke-associated pneumonia (SAP)13
COVID-19 vaccines and patients with multiple sclerosis: willingness, unwillingness and hesitancy: a systematic review and meta-analysis13
Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational study13
Translations and cultural adaptations of the Montreal Cognitive Assessment: a systematic and qualitative review13
Effect of pyridoxine plus pyridostigmine treatment on vincristine-induced peripheral neuropathy in pediatric patients with acute lymphoblastic leukemia: a single-center experience12
The effect of music therapy on language recovery in patients with aphasia after stroke: a systematic review and meta-analysis12
COVID-19 impact on neurology training program in Italy12
Neurophysiological and ultrasonographic comparative study of autonomous nervous system in patients suffering from fibromyalgia and generalized anxiety disorder12
Higher uric acid is associated with better discharge recovery and short-term outcome in stroke patients treated with thrombolysis12
Olfactory dysfunction is associated with motor function only in tremor-dominant Parkinson’s disease12
Episodic long-term memory in post-infectious SARS-CoV-2 patients12
Intravenous immunoglobulin as the rescue treatment in NMOSD patients12
The relationship between COVID-19’s severity and ischemic stroke: a systematic review and meta-analysis12
Natalizumab is associated with early improvement of working ability in relapsing-remitting multiple sclerosis patients: WANT observational study results12
Role of innate inflammation in traumatic brain injury12
Human viral encephalitis associated with suid herpesvirus 112
Advances in hyperekplexia and other startle syndromes12
Update on diagnosis and differential diagnosis of vestibular migraine12
GAD65 autoimmunity after treatment with nivolumab: a multifocal presentation12
Optimal MoCA cutoffs for detecting biologically-defined patients with MCI and early dementia12
Gastrointestinal dysfunction in movement disorders12
Cognitive and behavioral involvement in ALS has been known for more than a century12
Low serum uric acid levels are associated with the nonmotor symptoms and brain gray matter volume in Parkinson’s disease12
SARS-CoV-2 vaccine-related neurological complications12
Rescue therapies for seizure emergencies: current and future landscape12
Probiotic supplementation improved cognitive function in cognitively impaired and healthy older adults: a systematic review of recent trials12
Abstracts of the 52nd Annual Conference of the Italian Society of Neurology12
Arterial intracranial thrombosis as the first manifestation of vaccine-induced immune thrombotic thrombocytopenia (VITT): a case report12
Sleep disorders and mental health in hospital workers during the COVID-19 pandemic: a cross-sectional multicenter study in Northern Italy12
ASL MRI and 18F-FDG-PET in autoimmune limbic encephalitis: clues from two paradigmatic cases12
Clinical study on swallowing function of brainstem stroke by tDCS12
Impact of COVID-19 on neurological patients attending a botulinum toxin service12
The diagnosis and prognostic value of plasma copeptin in traumatic brain injury: a systematic review and meta-analysis12
Comparative safety of high-efficacy disease-modifying therapies in relapsing–remitting multiple sclerosis: a systematic review and network meta-analysis12
Down’s syndrome and COVID-19: risk or protection factor against infection? A molecular and genetic approach12
0.058947086334229